







































EU	equity	programmes	even	not	being	expressed	 target	of	 them	[11;	24].	Still,	 there	are	VC	capitalists	(VCists)	who	choose	portfolio	companies	on	criteria
























Industries	 for	 investing	 are	 important	 feature	 for	VC	 funds	 specialization.	 	 It	 is	widely	 accepted	 that	 specialization	 instead	 of	 diversification	 lets	VC	 funds




















































Still,	 literature	point	 that	not	all	NTBFs	are	 fast	growing	[11]	or	at	 least	 they	can	show	another	growth	 trajectory.	For	example,	 investments	 in	 life	sciences
industry	 usually	 are	 connected	with	more	 extended	 testing	 periods	 [4]	 and	 higher	 development	 costs.	 Therefore,	 the	 growth	 takes	 comparatively	 longer	 to
materialize	[24].
	











































factors	 influence.	 All	 of	 them	 have	 the	 same	 main	 LP	 –	 governmental	 agency	 and,	 as	 a	 result,	 are	 exposed	 to	 similar	 requirements.	 Only	 their	 partners'
knowledge	and	experience	are	differentiating	them.	Latvia	as	part	of	CEE	has	unmatured	VC	market	with	thin	supply	of	innovative	firms	and	small	funds	where











For	 industries	classification,	 standard	classification	 system	 in	EU	NACE	2nd	 revision	3-digit	 level	was	used.	To	understand	 in	what	 extent	 the	 faster	growth















The	 breakdown	 of	 investments’	 total	 amount	 in	 EUR	 in	Manufacturing	 by	 Eurostat	 classification	 is	 as	 follows:	 biggest	 amount	 went	 to	 Low	 technology
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